Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07110636 · ClinicalTrials.gov registry record · NA
Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
A NA study of Infection and Parasitic Disease, sponsored by Karius.
- Recruiting
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
- 6
- Study locations
NCT07110636 is a NA study of Infection and Parasitic Disease that is actively recruiting participants, run by Karius. The registered enrollment target is 2,000 participants, above the 678-participant average among 41 other Infection trials with a reported enrollment target (195% higher). The trial reports 6 study locations across 5 states.
The verdict
NCT07110636, a NA study of Infection and Parasitic Disease, is actively recruiting participants, sponsored by Karius.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
- 6
- Study locations
Study Summary
This clinical trial is designed to evaluate if adding the Karius Spectrum™ plasma test to usual care diagnostic tests, compared to usual care testing alone, among immunocompromised participants presenting with suspected infection in the outpatient setting leads to faster infection diagnosis and treatment. Participants will give a blood sample one time to be used for the testing. Information about the participant's illness and any treatments within 30 days following enrollment will be recorded.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Metagenomic plasma-based test for agnostic pathogen detection
Study Locations (6)
Massachusetts
- Brigham and Women's Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
California
- University of California San Francisco - San Francisco
Louisiana
- Ochsner Medical Center - New Orleans
Nebraska
- University of Nebraska Medical Center - Omaha
New York
- Montefiore Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2025-10-27 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07110636
The ClinicalTrials.gov registry entry for NCT07110636 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 678-participant average among 41 other Infection trials with a reported enrollment target (195% higher). The listed sponsor is Karius, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Infection appearing as the primary indexed condition, and to 1 intervention - of which Metagenomic plasma-based test for agnostic pathogen detection is the first listed.
NCT07110636 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Massachusetts, California, Louisiana.
Frequently Asked Questions
What is clinical trial NCT07110636 about?
NCT07110636 is a clinical study titled "Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients". This clinical trial is designed to evaluate if adding the Karius Spectrum™ plasma test to usual care diagnostic tests, compared to usual care testing alone, among immunocompromised participants presenting with suspected infection in the outpatient setting leads to faster infection diagnosis and trea...
What is the current status of trial NCT07110636?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2025-10-27. Estimated completion is 2028-12-31.
What conditions does trial NCT07110636 study?
This clinical trial studies the following conditions: Infection, Parasitic Disease, Infections, Bacterial, Infections, Fungal, Infection Viral.
What interventions are being tested in trial NCT07110636?
The interventions under investigation include: Metagenomic plasma-based test for agnostic pathogen detection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07110636?
This trial is sponsored by Karius, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07110636 being conducted?
This trial has 6 study locations across California, Louisiana, Massachusetts, Nebraska, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Copper Supplementation in Cirrhosis
RECRUITING · NA
-
BLOOM: Pragmatic Feasibility Trial
RECRUITING · NA
-
Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection
RECRUITING · NA
-
Remote Physician Care for Home Hospital Patients
COMPLETED · NA
-
CleanHands Sensor Based System to Improve Hand Hygiene and Reduce Infection
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.